Alzheimer’s disease (AD), the “second killer” in the diseases of the elderly, is a progressive neurodegenerative disease characterized by synaptic failure and cognitive deficit attributable to amyloid beta (Aβ) oligomers and hyperphosphorylated tau in the brain [1]. This evidence concerns the gene MAPT and Alzheimer disease.